This study will investigate the effect of smoking on the metabolism of a single oral dose of GW876008.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
26
GSK Investigational Site
Willingboro, New Jersey, United States
Blood levels of GW876008 collected on Day 1 at pre-dose and over 72 hours post-dose.
Time frame: on Day 1 at pre-dose and over 72 hours post-dose.
12-lead ECG on day 1, 24 hours post dose, & follow up
Time frame: on day 1, 24 hours post dose, & follow up
vital signs at screening & day 1 through 72 hours post dose
Time frame: at screening & day 1 through 72 hours post dose
adverse events day 1 through 72 hours post dose
Time frame: day 1 through 72 hours post dose
clinical laboratory data day 1 through 24 hours post dose
Time frame: day 1 through 24 hours post dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.